Report Feature
The future of nanoparticles in the global biotechnology and pharmaceutical market looks promising with opportunities in the drug delivery, drug discovery, studying cellular dynamics, and stem cell research applications. Nanoparticles in the global biotechnology and pharmaceutical market is expected to grow with a CAGR of 21%-23% from 2020 to 2025. The major drivers for this market are rising research and development activities in nanobiotechnology, increasing prevalence of chronic and infectious diseases due to sedentary lifestyle and unbalanced diets, and improving healthcare infrastructure.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of nanoparticles in the global biotechnology and pharmaceutical market report, please download the report brochure.
The study includes trends and forecast for nanoparticles in the global biotechnology and pharmaceutical market by product, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
- Fullerenes
- Liquid Crystals
- Liposomes
- Nanoshells
- Quantum Dots
- Superparamagnetic Nanoparticles
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
- Biotechnology
- Pharmaceutical
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- German
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Some of the biotechnology and pharmaceutical companies supplying nanoparticles and profiled in this report include Roche, GE Healthcare, Biogen, Novartis, Merck, Pfizer, AMAG Pharmaceuticals, Amgen, Celgene, and Bausch & Lomb.
Within this market, biotechnology will remain the largest segment by end user over the forecast period due to increasing drug development activities and rising demand for technologies to develop advanced products at reasonable costs.
North America will remain the largest region over the forecast period due to increasing prevalance of chronic diseases that require nanoparticles for treatment and therapies and rising awareness related to personalised medicines in the region.
|
Features of the Nanoparticles in the Global Biotechnology and Pharmaceutical Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for nanoparticles in the global biotechnology and pharmaceuticals market by product (fullerenes, liquid crystals, liposomes, nanoshells, quantum dots, and superparamagnetic nanoparticles), end user (biotechnology and pharmaceutical), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of nanoparticles in the global biotechnology and pharmaceuticals market? Q.5 What are the business risks and threats to nanoparticles in the global biotechnology and pharmaceuticals market? Q.6 What are the emerging trends in this nanoparticles in biotechnology and pharmaceuticals market and the reasons behind them? Q.7 What are some changing demands of customers in this nanoparticles in biotechnology and pharmaceuticals market? Q.8 What are the new developments in this nanoparticles in biotechnology and pharmaceuticals market? Which companies are leading these developments? Q.9 Who are the major players in this nanoparticles in biotechnology and pharmaceuticals market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this nanoparticles in biotechnology and pharmaceuticals market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in nanoparticles in the global biotechnology and pharmaceutical market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Product (Fullerenes, Liquid Crystals, Liposomes, Nanoshells, Quantum Dots, and Superparamagnetic Nanoparticles) and End User (Biotechnology and Pharmaceutical) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
7.2 Emerging Trends in the Nanoparticles in the Global Biotechnology and Pharmaceutical Market
4.1 Nanoparticles in the Global Biotechnology and Pharmaceutical Market by Region
4.2.1 Market by Product: Fullerenes, Liquid Crystals, Liposomes, Nanoshells, Quantum Dots, and Superparamagnetic Nanoparticles
4.2.2 Market by End User: Biotechnology and Pharmaceutical
4.2.3 The United States Nanoparticles in Biotechnology and Pharmaceuticals Market
4.2.4 The Canadian Nanoparticles in Biotechnology and Pharmaceuticals Market
4.2.5 The Mexican Nanoparticles in Biotechnology and Pharmaceuticals Market
4.3.1 Market by Product: Fullerenes, Liquid Crystals, Liposomes, Nanoshells, Quantum Dots, and Superparamagnetic Nanoparticles
4.3.2 Market by End User: Biotechnology and Pharmaceutical
4.3.3 The Nanoparticles in Biotechnology and Pharmaceuticals Market of United Kingdom
4.3.4 The German Nanoparticles in Biotechnology and Pharmaceuticals Market
4.3.5 The French Nanoparticles in Biotechnology and Pharmaceuticals Market
4.4.1 Market by Product: Fullerenes, Liquid Crystals, Liposomes, Nanoshells, Quantum Dots, and Superparamagnetic Nanoparticles
4.4.2 Market by End User: Biotechnology and Pharmaceutical
4.4.3 The Chinese Nanoparticles in Biotechnology and Pharmaceuticals Market
4.4.4 The Indian Nanoparticles in Biotechnology and Pharmaceuticals Market
4.4.5 The Japanese Nanoparticles in Biotechnology and Pharmaceuticals Market
7.1.1 Growth Opportunities for the Nanoparticles in the Global Biotechnology and Pharmaceutical Market by Product
7.1.2 Growth Opportunities for the Nanoparticles in the Global Biotechnology and Pharmaceutical Market by End User
7.1.3 Growth Opportunities for the Nanoparticles in the Global Biotechnology and Pharmaceutical Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
